Chiara Gerardi

Mario Negri Institute for Pharmacological Research

Papers

1

Total Citations

77

H-Index

1

About

Chiara Gerardi is a leading researcher in surgical oncology, with a primary focus on advancing minimally invasive techniques for complex hepatopancreaticobiliary procedures. Her most impactful work centers on the comparative effectiveness of robotic-assisted versus open pancreaticoduodenectomy, a notoriously challenging operation. In her landmark 2020 systematic review and meta-analysis, which has garnered 77 citations, Gerardi synthesized evidence from multiple studies to demonstrate that robotic-assisted approaches can offer significant short-term benefits—including reduced blood loss, shorter hospital stays, and lower complication rates—without compromising oncologic outcomes. This contribution has helped shape clinical decision-making and fueled the growing adoption of robotic surgery for periampullary malignancies. Beyond this meta-analysis, Gerardi’s broader research portfolio explores surgical quality improvement, patient selection for advanced technologies, and outcomes in benign and malignant disease. Her work is widely cited by surgeons and researchers seeking to balance innovation with evidence-based practice, establishing her as a key voice in the ongoing evolution of pancreatic surgery toward safer, less invasive standards.

Research Focus

Key Achievements

1
H-Index
1
Papers
77
Total Citations
77
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted versus open pancreaticoduodenectomy for patients with benign and malignant periampullary disease: a systematic review and meta-analysis of short-term outcomes
77 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Mario Negri Institute for Pharmacological Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago